Risk factors: Co-trimoxazole associated with increased mortality

Nature Reviews Nephrology 11, 2 (2015). doi:10.1038/nrneph.2014.212 New research suggests that administration of co-trimoxazole in patients aged ≥66 years receiving angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers is associated with an increased risk of sudden death compared with administration of amoxicillin. In this case-controlled study, approximately three deaths within 14 days occurred per 1,000
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Tags: Research Highlight Source Type: research